Stemtech Corp (STEK) income statement
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech Corp income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 75.7%
- Operating margin
- -134.0%
- Net margin
- -191.3%
- Return on equity, FY2025
- 70.7%
Financial strength
- Current ratio
- 0.05
- Debt to equity
- -0.02
- Debt to assets
- 4.3%
- Cash to current liabilities
- 2.3%
Valuation
- P/E ratio
- –
- Price to sales
- 0.16
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?